Dr Alex Dodoo

Dr Alex Dodoo

Dr Alex Dodoo, 45, a national of Ghana has been elected President of the

International Society of Pharmacovigilance for a three-year term ending at the ISoP general meeting in 2012.

The election took place at the ISoP annual conference in Reims, France.

Dr Dodoo, who takes over from Professor Nicholas Moore of the University of Bordeaux in France, becomes not just the first African but also the first non-European to be elected into this high and important position in global drug safety.

Dr Alex Dodoo is a pharmacist and clinical pharmacologist with degrees from the

University of Science and Technology, Kumasi, Ghana and King's College London, UK.

He also undertook a year of research at the University of Alberta, Edmonton,

Canada.
Dr Dodoo is currently the Head of the Centre for Tropical Clinical Pharmacology and

Therapeutics at the University of Ghana Medical School and leads the Global

Outreach team for the WHO Programme for International Drug Monitoring inUppsala Sweden.

Dr Alex Dodoo is a member of several global committees on drug safety. He is a member of the WHO Advisory Committee on the Safety of Medicinal Products (ACSoMP), the WHO Expert Panel on Drug Evaluation and a member-at-large of the WHO Global Advisory Committee on Vaccine Safety.

He is also a member of the Pharmaceutical Society of Ghana, the Royal Pharmaceutical Society of Great Britain and a Fellow of the West African Postgraduate College of Pharmacy Practice. He is the president of the Pharmaceutical Society of Ghana and also the president of the Pharmacy Information Section of the International Pharmaceutical Federation, based in The Hague.

The International Society of Pharmacovigilance (ISoP) is an international non-profit scientific organization, which aims to foster Pharmacovigilance both scientifically and educationally, and enhance all aspects of the safe and proper use of medicines, in all countries.

In addition to annual meetings in different countries, it also holds spring training courses on both basic and advanced pharmacovigilance. Its membership is drawn from industry, academia and national drug regulatory agencies.

Alexander Dodoo, President; Marie Lindquist, Vice-President; Eugène van Puijenbroek, Secretary General; Deirdre McCarthy, Treasurer; Mira Harrison-Woolrych, Vice-treasurer/secretary; Luis Alesso, Elliot Brown, Ulrich Hagemann, Hervé Le Louet, Ugo Moretti, Yola Moride, Executive Committee Members –Nicholas Moore, past-President